Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05087680 · ClinicalTrials.gov registry record · NA

An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South

A NA study of HIV Prevention, sponsored by Rhode Island Hospital.

Recruiting
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT05087680 is a NA study of HIV Prevention that is actively recruiting participants, run by Rhode Island Hospital. The registered enrollment target is 66 participants, below the 380-participant average among 32 other HIV Prevention trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05087680, a NA study of HIV Prevention, is actively recruiting participants, sponsored by Rhode Island Hospital.

RECRUITING
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

Investigators will use a generalized framework for the adaptation of EBIs to inform the development of a brief Acceptance and Commitment Therapy (ACT)-based culturally appropriate pre-exposure prophylaxis (PrEP) intervention tailored to young Black men who have sex with men (YBMSM), named ACTPrEP.

Conditions Studied

Interventions

  • BEHAVIORAL Enhanced Standard of Care
  • BEHAVIORAL ACTPrEP

Study Locations (1)

Mississippi

  • Univeristy of Mississippi Medical Center - Jackson

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2023-09-14
Est. Completion 2025-12-01
Phase NA

Sponsor

Rhode Island Hospital

130 total trials

What the Registry Record Tells You About NCT05087680

The ClinicalTrials.gov registry entry for NCT05087680 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 380-participant average among 32 other HIV Prevention trials with a reported enrollment target (83% lower). The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Prevention appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Standard of Care is the first listed.

NCT05087680 reports 1 study location spanning 1 distinct geographic area - top geographies include Mississippi.

Frequently Asked Questions

What is clinical trial NCT05087680 about?

NCT05087680 is a clinical study titled "An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South". Investigators will use a generalized framework for the adaptation of EBIs to inform the development of a brief Acceptance and Commitment Therapy (ACT)-based culturally appropriate pre-exposure prophylaxis (PrEP) intervention tailored to young Black men who have sex with men (YBMSM), named ACTPrEP.

What is the current status of trial NCT05087680?

This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2023-09-14. Estimated completion is 2025-12-01.

What conditions does trial NCT05087680 study?

This clinical trial studies the following conditions: HIV Prevention.

What interventions are being tested in trial NCT05087680?

The interventions under investigation include: Enhanced Standard of Care (BEHAVIORAL), ACTPrEP (BEHAVIORAL).

Who is sponsoring clinical trial NCT05087680?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05087680 being conducted?

This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.